Bio-Gate AG gross margin has been in long-term decline. The average rate of decline per year is -4.4%.
The historical rank and industry rank for Bio-Gate AG's Gross Margin % or its related term are showing as below:
XTER:BIG1'
s Gross Margin % Range Over the Past 10 Years
Min: 53.52 Med: 67.88 Max: 78.88
Current: 53.52
During the past 13 years, the highestGross Margin % of Bio-Gate AG was 78.88%. The lowest was 53.52%. And the median was 67.88%.
XTER:BIG1's Gross Margin % is ranked better than 51.07% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 52.61
vs XTER:BIG1: 53.52
Bio-Gate AG had a gross margin of 43.92% for the quarter that ended in Dec. 2023 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Bio-Gate AG was -4.40% per year.
Bio-Gate AG Gross Margin % Historical Data
The historical data trend for Bio-Gate AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bio-Gate AG's Gross Margin %
For the Medical Instruments & Supplies subindustry, Bio-Gate AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Gate AG's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Bio-Gate AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Bio-Gate AG (XTER:BIG1) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Bio-Gate AG had a gross margin of 43.92% for the quarter that ended in Dec. 2023 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Bio-Gate AG Gross Margin % Related Terms
Thank you for viewing the detailed overview of Bio-Gate AG's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
XTER:BIG1 has been successfully added to your 